Lipoprotein subfraction profiling in the search of new risk markers for myocardial infarction: The HUNT study
PLOS ONE · 2023
DOI: 10.1371/journal.pone.0285355 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Sigri Bakken Sperstad und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Circulation and Medical Imaging, NTNU, Trondheim, Norway. Hauptthemen laut MEDLINE: Lipoproteins, Myocardial Infarction. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Nasjonalforeningen for Folkehelsen, The Liaison Committee for education, research and innovation in Central Norway, The Joint Research Committee between St. Olavs hospital and the Faculty of Medicine and Health Sciences, NTNU.
Abstract (Originalsprache)
Background
Traditional biomarkers used to measure risk of myocardial infarction (MI) only explain a modest proportion of the incidence. Lipoprotein subfractions have the potential to improve risk prediction of MI.
Aim
We aimed to identify lipoprotein subfractions that were associated with imminent MI risk.
Methods
We identified apparently healthy participants with a predicted low 10-year risk of MI from The Trøndelag Health Survey 3 (HUNT3) that developed MI within 5 years after inclusion (cases, n = 50) and 100 matched controls. Lipoprotein subfractions were analyzed in serum by nuclear magnetic resonance spectroscopy at time of inclusion in HUNT3. Lipoprotein subfractions were compared between cases and controls in the full population (N = 150), and in subgroups of males (n = 90) and females (n = 60). In addition, a sub analysis was performed in participants that experienced MI within two years and their matched controls (n = 56).
Results
None of the lipoprotein subfractions were significantly associated with future MI when adjusting for multiple testing (p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Circulation and Medical Imaging, NTNU, Trondheim, Norway.
- Department of Biotechnology and Nanomedicine, SINTEF Industry, Trondheim, Norway.
- Clinic of Cardiology, St. Olavs University Hospital, Trondheim, Norway.
- Department of Public Health and Nursing, K.G. Jebsen Center for Genetic Epidemiology, Trondheim, Norway.
- Department of Medicine, Levanger Hospital, Nord-Trøndelag Hospital Trust, Levanger, Norway.
ORCID-Profile: Julie Caroline Sæther, Marie Klevjer
Förderung
- Nasjonalforeningen for Folkehelsen
- The Liaison Committee for education, research and innovation in Central Norway
- The Joint Research Committee between St. Olavs hospital and the Faculty of Medicine and Health Sciences, NTNU
Zitieren
APA
Sperstad, S. B., Sæther, J. C., Klevjer, M., Giskeødegård, G. F., Bathen, T. F., Røsbjørgen, R., Dalen, H., & Bye, A. (2023). Lipoprotein subfraction profiling in the search of new risk markers for myocardial infarction: The HUNT study. PLOS ONE. https://doi.org/10.1371/journal.pone.0285355
Vancouver
Sperstad SB, Sæther JC, Klevjer M, Giskeødegård GF, Bathen TF, Røsbjørgen R, et al. Lipoprotein subfraction profiling in the search of new risk markers for myocardial infarction: The HUNT study. PLOS ONE. 2023. doi:10.1371/journal.pone.0285355
BibTeX
@article{Sperstad2023,
author = {Sperstad, Sigri Bakken and Sæther, Julie Caroline and Klevjer, Marie and Giskeødegård, Guro Fanneløb and Bathen, Tone Frost and Røsbjørgen, Ragnhild and Dalen, Håvard and Bye, Anja},
title = {Lipoprotein subfraction profiling in the search of new risk markers for myocardial infarction: The HUNT study},
journal = {PLOS ONE},
year = {2023},
doi = {10.1371/journal.pone.0285355}
}
EUVIMED